Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2003 2
2004 1
2005 2
2006 1
2007 2
2008 2
2009 2
2010 3
2011 1
2012 7
2013 3
2014 3
2015 2
2016 4
2017 2
2018 13
2019 14
2020 11
2021 7
2022 4
2023 2
2024 1

Text availability

Article attribute

Article type

Publication date

Search Results

77 results

Results by year

Filters applied: . Clear all
Page 1
Triglyceride Lowering with Pemafibrate to Reduce Cardiovascular Risk.
Das Pradhan A, Glynn RJ, Fruchart JC, MacFadyen JG, Zaharris ES, Everett BM, Campbell SE, Oshima R, Amarenco P, Blom DJ, Brinton EA, Eckel RH, Elam MB, Felicio JS, Ginsberg HN, Goudev A, Ishibashi S, Joseph J, Kodama T, Koenig W, Leiter LA, Lorenzatti AJ, Mankovsky B, Marx N, Nordestgaard BG, Páll D, Ray KK, Santos RD, Soran H, Susekov A, Tendera M, Yokote K, Paynter NP, Buring JE, Libby P, Ridker PM; PROMINENT Investigators. Das Pradhan A, et al. N Engl J Med. 2022 Nov 24;387(21):1923-1934. doi: 10.1056/NEJMoa2210645. Epub 2022 Nov 5. N Engl J Med. 2022. PMID: 36342113 Clinical Trial.
Renal dysfunction, malignant neoplasms, atherosclerotic cardiovascular diseases, and sarcopenia as key outcomes observed in a three-year follow-up study using the Werner Syndrome Registry.
Maeda Y, Koshizaka M, Shoji M, Kaneko H, Kato H, Maezawa Y, Kawashima J, Yoshinaga K, Ishikawa M, Sekiguchi A, Motegi SI, Nakagami H, Yamada Y, Tsukamoto S, Taniguchi A, Sugimoto K, Takami Y, Shoda Y, Hashimoto K, Yoshimura T, Kogure A, Suzuki D, Okubo N, Yoshida T, Watanabe K, Kuzuya M, Takemoto M, Oshima J, Yokote K. Maeda Y, et al. Among authors: kawashima j. Aging (Albany NY). 2023 May 1;15(9):3273-3294. doi: 10.18632/aging.204681. Epub 2023 May 1. Aging (Albany NY). 2023. PMID: 37130431 Free PMC article.
Associated factors and effects of comorbid atrial fibrillation in hypertensive patients due to primary aldosteronism.
Sakaguchi S, Okamoto R, Inoue C, Akao M, Kamemura K, Kurihara I, Takeda Y, Ohno Y, Inagaki N, Rakugi H, Katabami T, Tsuiki M, Tanabe A, Tamura K, Fujita S, Yano Y, Dohi K; JRAS investigators; Naruse M. Sakaguchi S, et al. J Hum Hypertens. 2023 Sep;37(9):757-766. doi: 10.1038/s41371-022-00753-2. Epub 2022 Sep 24. J Hum Hypertens. 2023. PMID: 36153382
Impact of hepatic HSP72 on insulin signaling.
Kitano S, Kondo T, Matsuyama R, Ono K, Goto R, Takaki Y, Hanatani S, Sakaguchi M, Igata M, Kawashima J, Motoshima H, Matsumura T, Kai H, Araki E. Kitano S, et al. Among authors: kawashima j. Am J Physiol Endocrinol Metab. 2019 Feb 1;316(2):E305-E318. doi: 10.1152/ajpendo.00215.2018. Epub 2018 Dec 11. Am J Physiol Endocrinol Metab. 2019. PMID: 30532989 Free article.
The role of heat shock response in insulin resistance and diabetes.
Kondo T, Motoshima H, Igata M, Kawashima J, Matsumura T, Kai H, Araki E. Kondo T, et al. Among authors: kawashima j. Diabetes Metab J. 2014 Apr;38(2):100-6. doi: 10.4093/dmj.2014.38.2.100. Diabetes Metab J. 2014. PMID: 24851203 Free PMC article. Review.
Obesity as a Key Factor Underlying Idiopathic Hyperaldosteronism.
Ohno Y, Sone M, Inagaki N, Yamasaki T, Ogawa O, Takeda Y, Kurihara I, Umakoshi H, Ichijo T, Katabami T, Wada N, Ogawa Y, Yoshimoto T, Kawashima J, Watanabe M, Matsuda Y, Kobayashi H, Shibata H, Miyauchi S, Kamemura K, Fukuoka T, Yamamoto K, Otsuki M, Suzuki T, Naruse M; JPAS Study Group. Ohno Y, et al. Among authors: kawashima j. J Clin Endocrinol Metab. 2018 Dec 1;103(12):4456-4464. doi: 10.1210/jc.2018-00866. J Clin Endocrinol Metab. 2018. PMID: 30165444
Identification of microRNA that represses IRS-1 expression in liver.
Ono K, Igata M, Kondo T, Kitano S, Takaki Y, Hanatani S, Sakaguchi M, Goto R, Senokuchi T, Kawashima J, Furukawa N, Motoshima H, Araki E. Ono K, et al. Among authors: kawashima j. PLoS One. 2018 Jan 24;13(1):e0191553. doi: 10.1371/journal.pone.0191553. eCollection 2018. PLoS One. 2018. PMID: 29364977 Free PMC article.
Effect of Intraprocedural Cortisol Measurement on ACTH-stimulated Adrenal Vein Sampling in Primary Aldosteronism.
Kometani M, Yoneda T, Karashima S, Takeda Y, Tsuiki M, Yasoda A, Kurihara I, Wada N, Katabami T, Sone M, Ichijo T, Tamura K, Ogawa Y, Kobayashi H, Okamura S, Inagaki N, Kawashima J, Fujita M, Oki K, Matsuda Y, Tanabe A, Naruse M. Kometani M, et al. Among authors: kawashima j. J Endocr Soc. 2022 Jul 26;6(9):bvac104. doi: 10.1210/jendso/bvac104. eCollection 2022 Sep 1. J Endocr Soc. 2022. PMID: 35928241 Free PMC article.
Sex Differences in Renal Outcomes After Medical Treatment for Bilateral Primary Aldosteronism.
Nakamaru R, Yamamoto K, Akasaka H, Rakugi H, Kurihara I, Yoneda T, Ichijo T, Katabami T, Tsuiki M, Wada N, Yamada T, Kobayashi H, Tamura K, Ogawa Y, Kawashima J, Inagaki N, Fujita M, Oki K, Kamemura K, Tanabe A, Naruse M; JPAS/JRAS study group. Nakamaru R, et al. Among authors: kawashima j. Hypertension. 2021 Feb;77(2):537-545. doi: 10.1161/HYPERTENSIONAHA.120.16449. Epub 2020 Dec 28. Hypertension. 2021. PMID: 33356395
Subtype-specific trends in the clinical picture of primary aldosteronism over a 13-year period.
Saito K, Kurihara I, Itoh H, Ichijo T, Katabami T, Tsuiki M, Wada N, Yoneda T, Sone M, Oki K, Yamada T, Kobayashi H, Tamura K, Ogawa Y, Kawashima J, Inagaki N, Yamamoto K, Yamada M, Kamemura K, Fujii Y, Suzuki T, Yasoda A, Tanabe A, Naruse M; Japan Primary Aldosteronism Study/Japan Rare Intractable Adrenal Diseases Study Group. Saito K, et al. Among authors: kawashima j. J Hypertens. 2021 Nov 1;39(11):2325-2332. doi: 10.1097/HJH.0000000000002924. J Hypertens. 2021. PMID: 34224538
77 results